CONFERENCES

      International Association for Dental Research

      This is an annual conference, hosted by International Association of Dental Research (IADR), American Association for Dental Research (AADR) and Canadian Association for Dental Research (CADR), that focuses on the latest developments in dental research, with topics ranging from clinical practice to basic science. The conference is aimed at dental researchers, clinicians, and other professionals involved in the study and practice of dentistry, and provides a forum for sharing knowledge and collaborating on new approaches to improving dental health.

      IADR/AADR/CADR General Session 2021

      Date

      Jul 21, 2021 - Jul 24, 2021

      Location

      Online

      Bringing over 3,000 participants from 85 countries, the 99th General Session of the IADR, the 50th Meeting of the AADR and the 45th Meeting of the CADR include 71 symposia and 1,847 poster presentations.

      See related posters

      IADR/AADR/CADR General Session 2019

      Date

      Jun 19, 2019 - Jun 22, 2019

      Location

      Vancouver, Canda

      The 97th General Session of the International Association for Dental Research (IADR), is held in conjunction with the 48th Annual Meeting of the American Association for Dental Research (AADR) and the 43rd Annual Meeting of the Canadian Association for Dental Research (CADR). Bringing over 5,000 participants from 81 countries, the IADR/AADR/CADR General Session includes 72 symposia and 2,672 poster presentations.

      IADR/AADR/CADR General Session 2017

      Date

      Mar 21, 2017 - Mar 25, 2017

      Location

      San Francisco, USA

      95th General Session & Exhibition of the International Association for Dental Research (IADR) is co-hosted with the 46th Annual Meeting of the American Association for Dental Research (AADR) and the 41st Annual Meeting of the Canadian Association for Dental Research (CADR).

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.